Vibhavadi Medical Center PCL (BKK:VIBHA)
1.530
-0.030 (-1.92%)
Apr 4, 2025, 4:29 PM ICT
BKK:VIBHA Cash Flow Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 698.61 | 865.12 | 1,340 | 1,805 | 465.47 | Upgrade
|
Depreciation & Amortization | 633.42 | 640.45 | 620.24 | 497.65 | 434.09 | Upgrade
|
Other Amortization | 7.32 | 6.06 | 4.26 | 3.36 | 4.6 | Upgrade
|
Loss (Gain) From Sale of Assets | 6.8 | 1.92 | 13.9 | 2.68 | 2.24 | Upgrade
|
Asset Writedown & Restructuring Costs | 33.21 | - | - | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | 214.93 | 153.87 | 64.99 | 11.23 | -19.59 | Upgrade
|
Loss (Gain) on Equity Investments | -65.9 | -73.74 | -135.71 | -721.69 | 62.35 | Upgrade
|
Provision & Write-off of Bad Debts | 54.63 | 30.14 | 29.1 | 8.47 | 5.24 | Upgrade
|
Other Operating Activities | 122.91 | 95.57 | 152.32 | 156.78 | 88.59 | Upgrade
|
Change in Accounts Receivable | 31.94 | 106.04 | -14.23 | -346.61 | -64.67 | Upgrade
|
Change in Inventory | -5.35 | 6.79 | 217.87 | -17.51 | 9.63 | Upgrade
|
Change in Accounts Payable | 28.06 | -41.07 | 37.2 | 59.71 | -7.13 | Upgrade
|
Change in Unearned Revenue | -9.36 | 14.66 | 4.77 | 38.45 | 77.08 | Upgrade
|
Change in Other Net Operating Assets | 44.22 | 12.86 | -328.68 | 212.57 | 36.83 | Upgrade
|
Operating Cash Flow | 1,795 | 1,819 | 1,970 | 1,672 | 1,095 | Upgrade
|
Operating Cash Flow Growth | -1.28% | -7.68% | 17.83% | 52.71% | -28.29% | Upgrade
|
Capital Expenditures | -593.74 | -506.31 | -424.82 | -956.93 | -1,488 | Upgrade
|
Sale of Property, Plant & Equipment | 8.31 | 4.83 | 2.39 | 0.17 | 0.63 | Upgrade
|
Cash Acquisitions | - | -4.15 | - | - | - | Upgrade
|
Divestitures | -0.95 | - | 13.38 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -2.59 | -16.34 | -4.85 | -8.19 | -7.86 | Upgrade
|
Investment in Securities | -783.9 | -278.28 | -858.75 | -1,357 | -494.13 | Upgrade
|
Other Investing Activities | 429.08 | 503.71 | 618.02 | 405.11 | 343.59 | Upgrade
|
Investing Cash Flow | -941.99 | -318.44 | -688.29 | -1,929 | -1,669 | Upgrade
|
Short-Term Debt Issued | 1,261 | 22.07 | - | 1,216 | 14.5 | Upgrade
|
Long-Term Debt Issued | 726.6 | 1,571 | 1,153 | 1,804 | 2,013 | Upgrade
|
Total Debt Issued | 1,987 | 1,593 | 1,153 | 3,019 | 2,028 | Upgrade
|
Short-Term Debt Repaid | - | -459.36 | -206.73 | -4 | -72.04 | Upgrade
|
Long-Term Debt Repaid | -1,565 | -1,594 | -1,303 | -1,716 | -1,127 | Upgrade
|
Total Debt Repaid | -1,565 | -2,053 | -1,509 | -1,720 | -1,199 | Upgrade
|
Net Debt Issued (Repaid) | 422.55 | -460.03 | -356.29 | 1,299 | 828.83 | Upgrade
|
Issuance of Common Stock | - | - | 0.44 | - | 310.94 | Upgrade
|
Repurchase of Common Stock | -194.23 | - | - | - | - | Upgrade
|
Common Dividends Paid | -816.48 | -890.5 | -774.95 | -665.85 | -639.09 | Upgrade
|
Other Financing Activities | -323.07 | -152.93 | -227.8 | -203.01 | -190.7 | Upgrade
|
Financing Cash Flow | -911.23 | -1,503 | -1,359 | 430.39 | 309.98 | Upgrade
|
Net Cash Flow | -57.78 | -3.23 | -77.01 | 173.49 | -264.56 | Upgrade
|
Free Cash Flow | 1,202 | 1,312 | 1,545 | 714.83 | -393.73 | Upgrade
|
Free Cash Flow Growth | -8.43% | -15.06% | 116.15% | - | - | Upgrade
|
Free Cash Flow Margin | 13.85% | 15.78% | 17.62% | 9.55% | -6.40% | Upgrade
|
Free Cash Flow Per Share | 0.09 | 0.10 | 0.11 | 0.05 | -0.03 | Upgrade
|
Cash Interest Paid | 345.56 | 304.52 | 248.35 | 204.14 | 192.08 | Upgrade
|
Cash Income Tax Paid | 220.1 | 273.36 | 328.73 | 162.2 | 163.53 | Upgrade
|
Levered Free Cash Flow | 719.19 | 778.78 | 1,125 | 434.99 | -771.28 | Upgrade
|
Unlevered Free Cash Flow | 934.58 | 970.24 | 1,278 | 563.76 | -644.58 | Upgrade
|
Change in Net Working Capital | -153.79 | -35.42 | 42.82 | -173.5 | 47.86 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.